Abbott to close Puerto Rico manufacturing plant

January 30, 2014 by Danica Coto

Abbott Laboratories is closing one of its manufacturing plants in the Puerto Rico town of Barceloneta next year, delivering another blow to the U.S. territory's once-thriving pharmaceutical sector, officials said Thursday.

It is unclear how many workers will be affected, although Barceloneta Mayor Wanda Soler told The Associated Press that the plant is the smallest one of several that Abbott operates in the north coastal town.

Abbott spokesman Scott Stoffel confirmed that the plant would cease in mid-2015. He declined to say how many employees work there, but said the company employs a total of 1,500 people across Puerto Rico.

Abbott is the latest pharmaceutical company to announce a closure in Barceloneta, which with operations of two other U.S. drug companies was once the island's manufacturing hub.

In November, drug giants Pfizer Inc. and Merck & Co. released statements about a week apart announcing they would phase out their operations in Barceloneta. Both Pfizer and Merck said they would continue to manufacture elsewhere in Puerto Rico, and neither gave specific numbers on job losses since some positions would transfer.

Abbott's announcement comes as Puerto Rico tries to revive its economy under pressure from credit rating agencies as it enters an eighth year of recession and battles a 15.4 percent unemployment rate, higher than any U.S. state.

Puerto Rico is still among the world's leading centers for pharmaceutical manufacturing, and the sector accounts for roughly a quarter of the island's economy, but the sector has been in retreat. Since 2000, when they had about 20,000 employees on the island, drug makers have eliminated more than 9,000 jobs, hitting Barceloneta and nearby towns along the island's north-central coast.

"It's a bit worrisome, I have to admit," Barceloneta's mayor said. She added that she is working with the island's government to attract new business. "We have several plants that are in perfect condition."

Antonio Medina, executive director of Puerto Rico's Industrial Development Company, said officials are offering incentives for existing to expand. The government also hopes to diversify the manufacturing base by expanding in such sectors as aerospace and information technology, lessening the importance of pharmaceuticals, he said in a recent interview.

"The healthiest economy is one that is highly diversified," Medina said. "No one sector can be the economy's magic wand."

Explore further: Puerto Rico warns about dwindling numbers of frogs (Update)

Related Stories

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.